Dianthus Therapeutics, Inc. (DNTH) short interest & options flow
NASDAQDianthus Therapeutics enters the back half of September with an uncomfortable combination: the stock is down 9% on the week and 16% over the past month, yet short interest has quietly crept to 20% of the free float — and JP Morgan just stepped in with a fresh Overweight initiation. The short-interest story is the most important tension here. Bears hold a meaningful position — 20%…
- Market cap
- $4.84B
- Next earnings
- 11 Nov 2026
Key data as of 8 Nov 2026

DNTH news and analysis
RSSNo long-form analysis yet for DNTH. Pulse alerts and the live data picture are available on ORTEX.
Open DNTH on ORTEX →Want the live picture for DNTH?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DNTH — free to start on ORTEX.
Sign up for free →Open DNTH on ORTEX